PMID: 9639077Jun 25, 1998Paper

Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment

Journal of Child and Adolescent Psychopharmacology
Daniel F ConnorR H Melloni

Abstract

The prevalence and patterns of use of psychiatric and anticonvulsant medications were studied in 83 seriously emotionally disturbed children and adolescents at the time of their admission to a residential treatment facility. Youths (aged 5-19, mean = 13.6 years), consecutively admitted over 17 months, were assessed for the prevalence and patterns of use of psychotropic and anticonvulsant treatments. At admission, 76% of the youths were receiving psychiatric pharmacotherapy, 40% with more than one psychiatric agent, and 15% with a combination of psychotropic and anticonvulsant medications. Frequently prescribed medications were neuroleptics (35 % of the medicated youths), sedative-hypnotics (26 %), and anticonvulsants (15%). Psychostimulants (16%) and antidepressants (22%) were under-prescribed relative to their diagnostic indications. Over 50 different medication combinations were used. The neuroleptic + lithium combination was most common (25 % of the polypharmacological treatments). Neuroleptics were the most commonly prescribed medication and mostly used for nonpsychotic, nontic, and nonbipolar indications (55% of neuroleptic trials). Neuroleptics were used primarily for aggression regardless of diagnosis. Neuroleptics were ...Continue Reading

References

Dec 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·M G AmanG Sarphare

❮ Previous
Next ❯

Citations

Jul 17, 2004·The Journal of Behavioral Health Services & Research·Purva H RawalJohn C Hunter
Jan 16, 2013·The Journal of Behavioral Health Services & Research·Leslie MillerSusan dosReis
Apr 29, 2004·The American Journal of Orthopsychiatry·Daniel F ConnorRichard H Melloni
Aug 22, 2002·Journal of Child and Adolescent Psychopharmacology·Andre SouranderEeva T Aronen
May 25, 2005·Journal of Child and Adolescent Psychopharmacology·Daniel F Connor, Thomas J McLaughlin
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·Jud A StallerMolly Baker
Nov 6, 2007·Journal of Child and Adolescent Psychopharmacology·Lynn A WarnerKathleen J Pottick
Oct 22, 2008·Journal of Child and Adolescent Psychopharmacology·Michael L HandwerkDaniel L Daly
Nov 21, 2013·Journal of Child and Adolescent Psychopharmacology·Pieter Joost van WattumTodd Johnson
Jun 7, 2014·Journal of Child and Family Studies·Sharon L BrennerElizabeth M Z Farmer
Sep 20, 2007·Expert Opinion on Drug Safety·Camilla Haw, Jean Stubbs
Mar 6, 2004·Annals of the New York Academy of Sciences·Daniel F ConnorRichard H Melloni
Sep 10, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Richard SnyderUNKNOWN Risperidone Conduct Study Group
Apr 25, 2020·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Clare EinbergerRichard Melloni
Nov 17, 2007·Annals of General Psychiatry·Helen LazaratouDimitris N Ploumpidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of Child and Adolescent Psychopharmacology
Daniel F Connor, Thomas J McLaughlin
BMJ : British Medical Journal
S N Wolkind
© 2022 Meta ULC. All rights reserved